DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
Neal Freedman, Ph.D., has been appointed as DCEG’s principal investigator for the Prostate, Lung, Colon, and Ovary (PLCO) Screening Trial, a large, population-based screening trial whose resources support a range of molecular epidemiologic studies. Read more about Dr. Freedman's appointment.
DCEG recently hosted the first workshop to review findings from the MicroBiome Quality Control (MBQC) Project. The MBQC Project is a collaborative effort to comprehensively evaluate appropriate methodologies for this growing field of research, including variability in microbial assessment in sampling handling (including DNA extraction, DNA amplification, and sequencing) and bioinformatics. Read more about the Microbiome Quality Control Workshop.
In September, several members of the Radiation Epidemiology Branch (REB) participated in the 2014 Conference on Radiation and Health in Las Vegas, Nevada. The theme of the conference was "The Public Health Impact of Current Sources of Radiation Exposures, New Data and Insights from Biology, Epidemiology, and Statistics." REB scientists and fellows contributed by chairing sessions, giving talks, and presenting posters during the conference. Read more about REB participation in the 2014 Conference on Radiation and Health.
In September, DCEG welcomed Visiting Scholar Dr. David Hunter, the Vincent L. Gregory Professor in Cancer Prevention in the Departments of Epidemiology and Nutrition and Dean for Academic Affairs at the Harvard T.H. Chan School of Public Health. His principal research interest is the etiology of breast cancer, with a focus on genetic susceptibility and gene-environment interactions. Dr. Hunter presented a seminar titled “Global cancer trends and what we can do about them.” His talk touched on a pivotal issue for all cancer epidemiologists: what steps can be taken to reduce cancer incidence and death? Read more about Visiting Scholar David Hunter.
Joseph F. Fraumeni, Jr., M.D., former Director of DCEG, has been chosen to receive the William G. Anlyan, M.D., Lifetime Achievement Award from the Duke Medical Alumni Association. In announcing the award, Dr. Nancy C. Andrews, Dean of the Duke University School of Medicine, cited Dr. Fraumeni’s “numerous and far-reaching contributions …to epidemiology and environmental health during his career at the National Cancer Institute.” Read more about Dr. Fraumeni.
Xiaohong Rose Yang, Ph.D., M.P.H., was recently awarded scientific tenure by the NIH. Dr. Yang seeks to identify susceptibility genes for rare cancers that sometimes aggregate in families. To carry out this work she employs cutting-edge genomic technologies and novel statistical approaches to uncover genetic changes associated with risk for several familial cancers including melanoma and dysplastic nevi syndrome and chordoma. In her investigation of etiologic heterogeneity of breast cancer, Dr. Yang characterizes the molecular signature of tumors using tissue microarray and integrated tumor profiling analyses to identify risk factors for specific cancer subtypes. Learn more about Dr. Yang's research.
In August, DCEG scientists participated in the 29th International Papillomavirus Conference in Seattle, Washington. The meeting highlighted basic, clinical, and public health science topics ranging from molecular virology to novel cancer screening and treatment strategies to global public health.
Aimée R. Kreimer, Ph.D., presented a plenary talk on “Oral HPV natural history and its progression to oropharyngeal cancer.” View a list of other DCEG speakers and participants at the conference.
In July, Christian C. Abnet, Ph.D., M.P.H., was named Acting Chief of the Nutritional Epidemiology Branch (NEB). Dr. Abnet joined NCI as a Cancer Prevention Fellow in 1998, became a tenure-track investigator in NEB in 2005, and was awarded tenure in May 2014.
Over the past 14 years, researchers in the Clinical Genetics Branch (CGB), led by Branch Chief Sharon Savage, M.D., have carried out a study of dyskeratosis congenita (DC) at the NIH Clinical Center to better understand the disorder and to identify the genes responsible for it.
Using exome sequencing, Dr. Savage and her team have identified several genes that cause DC, including RTEL1, a gene known to be involved in telomere biology. Discovery of a rare founder mutation in this gene has led to a direct benefit for at least one DC family. Read more about this discovery.View an archive of past people in the news.